Clinical trial for SCHIZOPHRENIA 1 (Disorder)
Official title Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
ClinicalTrials.gov ID: NCT07853807
What this study is testing
- What it's testing
- The study aims to find out whether these tasks can predict how much a person experiences hallucinations or delusions, and to compare how well each task works.
- Who it's for
- Adults who have schizophrenia, schizoaffective disorder, or no mental illness.
- What's involved
- Participants will complete a series of computer‑based cognitive tasks and may have an EEG (brain‑wave) recording taken while they do the tasks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59. Healthy volunteers may be eligible.
You may be able to join if
- General Inclusion
- age 18 to 59
- no substance disorder in past six months (confirmed with urine drug screens and breathalyzers);
- Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnosis of schizophrenia or schizoaffective;
- no medication changes in prior month or anticipated in the next month or not taking medications
You likely can't join if
- Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder diagnosis
- not in acute exacerbation requiring immediate hospitalization or treatment
- self-reported medication non-compliance for at least the four previous weeks 3)never having started medications
See the full eligibility criteria
- General Inclusion
- age 18 to 59
- no substance disorder in past six months (confirmed with urine drug screens and breathalyzers);
- Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnosis of schizophrenia or schizoaffective;
- no medication changes in prior month or anticipated in the next month or not taking medications
- no Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder;
- no family history of psychosis or bipolar
- Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder diagnosis
- not in acute exacerbation requiring immediate hospitalization or treatment
- self-reported medication non-compliance for at least the four previous weeks 3)never having started medications
The study team makes the final eligibility decision.
Where it is enrolling
- Irvine, California, United States
- Chicago, Illinois, United States
- Baltimore, Maryland, United States
- Minneapolis, Minnesota, United States
- St Louis, Missouri, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Irvine, California, United States; Chicago, Illinois, United States; Baltimore, Maryland, United States; Minneapolis, Minnesota, United States; St Louis, Missouri, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.